REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,849,000 | +8.9% | 47,574 | -2.9% | 0.01% | 0.0% |
| Q1 2023 | $4,453,000 | +123.4% | 48,978 | -6.5% | 0.01% | +100.0% |
| Q4 2022 | $1,993,000 | +41.0% | 52,395 | -6.7% | 0.01% | +25.0% |
| Q3 2022 | $1,413,000 | -17.1% | 56,150 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,705,000 | -4.6% | 56,015 | +2.8% | 0.00% | 0.0% |
| Q1 2022 | $1,787,000 | +23.6% | 54,515 | -0.6% | 0.00% | +33.3% |
| Q4 2021 | $1,446,000 | -75.7% | 54,823 | -7.2% | 0.00% | -81.2% |
| Q3 2021 | $5,944,000 | -39.4% | 59,090 | -14.7% | 0.02% | -42.9% |
| Q2 2021 | $9,802,000 | +66.8% | 69,260 | +17.5% | 0.03% | +47.4% |
| Q1 2021 | $5,878,000 | -19.4% | 58,958 | -0.1% | 0.02% | -36.7% |
| Q4 2020 | $7,297,000 | +36.6% | 58,993 | +7.6% | 0.03% | +15.4% |
| Q3 2020 | $5,341,000 | – | 54,838 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |